IP Library Granted Patent US 7,998,752
Granted Patent B2
US 7,998,752 · App. 11/950,706 · Granted Aug 16, 2011

Biosensor and blood component analytical method

Assignee: Panasonic Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,998,752
App. No.
11/950,706
Granted
Aug 16, 2011
Kind
B2
Abstract

According to the biosensor and the blood component analytical method of the present invention, in a biosensor that is made of a single layer or plural layers of a porous material as shown in FIG. 1 , having a reagent holding part and utilizing chromatography, a cell shrinkage reagent is carried on at least part of the reagent holding part, or at least part of a chromatographically developed part that is upstream of the reagent holding part. According to the biosensor having the above-mentioned structure and the blood component analytical method, even when whole blood is a sample, a high-accuracy blood component analysis cart be performed easily and quickly with less cost.

Claims (11)

1. A blood component analytical method which employs a biosensor that is made of a single layer or plural layers of a porous material which develops shrunk cells, said biosensor having a reagent holding part which holds a reagent for analyzing an analyte in a blood specimen, a carrier, and a reaction layer chromatographically downstream of said carrier wherein said biosensor analyzes target components in the blood specimen by utilizing chromatography, said analytical method comprising the steps of:

adding said blood specimen to a specimen addition part of said biosensor;

shrinking cell components of said blood specimen using a cell shrinkage reagent of said biosensor that is disposed on at least a part of an area of said biosensor, said area ranging from said specimen addition part to which the blood specimen is added to the reagent holding part thereof, wherein said cell shrinkage agent is dissolved from the area carrying said cell shrinkage reagent by the blood specimen added to the specimen addition part and infiltrating into the area carrying the cell shrinkage reagent and in which the resulting shrunk cell components are smaller;

chromatographically permeating the cell components in a state where shrunk cell components included in the blood specimen are mixed with the blood specimen;

marking the analyte in the blood specimen which is chromatographically permeated with the reagent which has been held in the reagent holding part, wherein the shrunk cell components are permeated together with the blood specimen toward said reaction layer that is provided chromatographically downstream, wherein the shrunk cell components and the blood specimen are permeated into the reaction layer in a state where each of the shrunk cell components and the blood specimen are mixed; and

performing the analysis of the analyte in the blood specimen in said reaction layer in which a reaction of the analyte in the blood specimen and the reagent which is dissolved from the reagent holding part is first carried out,

wherein the cell shrinkage agent is sodium chloride, potassium chloride, or sodium phosphate.

2. The blood component analytical method of claim 1 wherein a blood specimen to be added is whole blood.

3. The blood component analytical method of claim 1 wherein the concentration of sodium chloride, potassium chloride, or sodium phosphate is in the range of about 0.1 to about 5.0M.

4. The blood component analytical method of claim 1 wherein the biosensor is a one-step immunochromatographic test strip.

5. The blood component analytical method of claim 1 wherein the biosensor is a dry analytical element.

Assignments (7)
CHANGE OF NAME Recorded Jun 29, 2018
From: PANASONIC HEALTHCARE HOLDINGS CO., LTD.
To: PHC HOLDINGS CORPORATION
Reel/Frame 046459/0861 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 29, 2014
From: PANASONIC CORPORATION
To: PHC HOLDINGS CO., LTD.
Reel/Frame 032785/0498 →
CHANGE OF NAME Recorded Apr 29, 2014
From: PHC HOLDINGS CO., LTD.
To: PANASONIC HEALTHCARE HOLDINGS CO., LTD.
Reel/Frame 032785/0563 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 19, 2014
From: PANASONIC HEALTHCARE CO., LTD.
To: PANASONIC CORPORATION
Reel/Frame 032480/0433 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 27, 2014
From: PANASONIC CORPORATION
To: PANASONIC HEALTHCARE CO., LTD.
Reel/Frame 032360/0795 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 10, 2011
From: TAKAHASHI, MIE; NADAOKA, MASATAKA; TANAKA, HIROTAKA; KITAWAKI, FUMIHISA
To: MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD.
Reel/Frame 025785/0995 →
CHANGE OF NAME Recorded Feb 10, 2011
From: MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD.
To: PANASONIC CORPORATION
Reel/Frame 025786/0395 →
Priority Claims (1)
JP 2000-164990 · Jun 1, 2000 · national
Continuity (2)
Division 10049366
Related Publication 20080085561A1 · Apr 10, 2008